OpenNeedle Ask your own

Question explored with the scientific record

Has photobiomodulation effect on backpain

Nov 1, 2026 · 4 sources used · OpenNeedle synthesis
The short version: for ordinary low back pain, the best evidence says light therapy doesn't work well enough to bother with.

A 2020 systematic review of 12 randomized trials found that photobiomodulation (laser or LED light therapy) did not produce a worthwhile reduction in pain or disability for people with chronic nonspecific low back pain, compared with a fake (sham) treatment [1]. The pain difference was too small to matter, and the evidence quality was rated low [1]. For acute or subacute back pain, adding light therapy to hot packs was unlikely to help either [1]. When compared head-to-head with exercise, there was no clinically important difference [1]. One small subgroup hinted that a proper dose of light therapy added to exercise might reduce pain, but the authors themselves said it was unclear whether that effect was real or trivial [1].

ComparisonResultEvidence quality
Light therapy vs sham, chronic painNo worthwhile effectLow [1]
Light therapy vs sham, disabilityNo worthwhile effectLow [1]
Light therapy + hot packs vs sham, acute painUnlikely to helpLow [1]
Light therapy vs exerciseNo important differenceVery low [1]

The mechanism story is real but doesn't rescue the clinical result. In mice, 810 nm light aimed at the lower-back nerve roots raised pain thresholds in a dose-dependent way, with no tolerance over 7 days [2]. That's a plausible biological signal, not proof it helps a human with back pain. Lab studies on spinal disc cells suggest light might influence tissue-repair enzymes, but that's a dish, not a person [3]. The dose-response is also tricky: too little light does nothing and too much can backfire, which is one reason trials disagree [4].

This retrieval is thin on long-term outcomes and on who funded the back-pain trials. It cannot tell you whether any trial showed a benefit that a later, larger one failed to replicate.

My call: for nonspecific low back pain, don't pay for photobiomodulation expecting relief; the best available synthesis says the effect is too small to be worthwhile. It appears low-risk, but low-risk and ineffective is still not worth your money. Confidence: moderate.

Keep digging

Sources used 4

  1. Photobiomodulation therapy does not decrease pain and disability in people with non-specific low back pain: a systematic review Journal of Physiotherapy (2020) systematic review Strong

    Current evidence from 12 randomised trials does not support photobiomodulation therapy to decrease pain and disability in people with non-specific low back pain.

    DOI: 10.1016/j.jphys.2020.06.010
  2. Pain management using photobiomodulation: Mechanisms, location, and repeatability quantified by pain threshold and neural biomarkers in mice Journal of Biophotonics (2018) Thin

    In adult BALB/c mice, transcutaneous 810 nm photobiomodulation targeted to the dorsal root ganglion (lower back) increases hind-paw pain threshold in a dose- and time-dependent manner, shows no tolerance with daily treatment for 7 days, and is accompanied by DRG biomarker change…

    DOI: 10.1002/jbio.201700370
  3. Photobiomodulation on human annulus fibrosus cells during the intervertebral disk degeneration: extracellular matrix-modifying enzymes Lasers in Medical Science (2016) Thin

    This study investigates the effects of photobiomodulation on extracellular matrix-modifying enzymes in human annulus fibrosus cells under degenerative conditions induced by pro-inflammatory cytokines, suggesting its potential as a therapeutic tool for intervertebral disk degener…

    DOI: 10.1007/s10103-016-1923-x
  4. Biphasic Dose Response in Low Level Light Therapy – an Update Dose-Response (2011) Thin

    This 2009 update reviews the biphasic (Arndt-Schulz) dose response in low-level light therapy (photobiomodulation), synthesizing in vitro, in vivo, and clinical evidence to explain why low doses can be beneficial while higher doses may be inhibitory or harmful, and highlighting …

    DOI: 10.2203/dose-response.11-009.hamblin

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →